Header cover image

German (DAX) Life Sciences Industry Analysis

UpdatedAug 16, 2026
DataAggregated Company Financials
Companies6
  • 7D1.4%
  • 3M11.4%
  • 1Y6.7%
  • YTD0.4%

In the last week, the Life Sciences industry is up 1.4%, with Gerresheimer up 3.3%. This takes the industry's 12 month performance to a gain of 6.7%. As for the next few years, earnings are expected to grow by 24% per annum.

Industry Valuation and Performance

Has the German Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 16 Aug 2026€19.7b€7.6b-€185,627,633.5254x-106x2.6x
Tue, 14 Jul 2026€20.6b€7.6b-€209,218,561.8763.9x-98.3x2.7x
Thu, 11 Jun 2026€19.0b€7.5b€134.4m36.5x141.1x2.5x
Sat, 09 May 2026€17.7b€7.6b€231.8m40.4x76.6x2.3x
Mon, 06 Apr 2026€16.6b€7.5b€168.6m27.5x98.7x2.2x
Wed, 04 Mar 2026€17.6b€7.5b€168.6m23.8x104.5x2.3x
Fri, 30 Jan 2026€19.1b€7.5b€143.5m37.9x133.3x2.5x
Sun, 28 Dec 2025€19.2b€7.5b€143.5m39.8x133.7x2.6x
Tue, 25 Nov 2025€18.9b€7.5b€143.9m35.9x131.1x2.5x
Thu, 23 Oct 2025€20.2b€7.5b€147.4m41x136.8x2.7x
Sat, 20 Sep 2025€19.2b€7.4b€157.8m24.4x121.5x2.6x
Mon, 18 Aug 2025€18.5b€7.4b€157.8m24.6x117.4x2.5x
Wed, 16 Jul 2025€20.2b€7.4b€99.5m27.3x202.8x2.7x
Fri, 13 Jun 2025€20.5b€7.3b€114.9m30.6x178.3x2.8x
Sun, 11 May 2025€21.7b€7.3b€101.5m28.6x213.6x3x
Tue, 08 Apr 2025€17.0b€7.1b€156.5m23.1x108.6x2.4x
Thu, 06 Mar 2025€22.4b€7.1b€156.5m29.3x142.8x3.1x
Sat, 01 Feb 2025€24.8b€7.1b€169.8m23.7x146x3.5x
Mon, 30 Dec 2024€21.4b€7.1b€169.8m25.1x126x3x
Wed, 27 Nov 2024€21.9b€7.1b€170.5m27x128.2x3.1x
Fri, 25 Oct 2024€24.3b€7.1b€171.2m32x142.2x3.4x
Sun, 22 Sep 2024€23.5b€7.1b€172.8m30.5x135.8x3.3x
Tue, 20 Aug 2024€24.0b€7.0b€157.1m35.4x153x3.4x
Thu, 18 Jul 2024€25.3b€7.0b€307.9m38x82.2x3.6x
Sat, 15 Jun 2024€24.3b€7.0b€333.3m29.7x72.9x3.5x
Mon, 13 May 2024€28.0b€7.0b€340.1m34.9x82.2x4x
Wed, 10 Apr 2024€33.9b€7.1b€384.5m38.4x88.2x4.8x
Fri, 08 Mar 2024€34.1b€7.1b€384.5m35.6x88.6x4.8x
Sun, 04 Feb 2024€31.5b€7.3b€516.3m35.5x61x4.3x
Tue, 02 Jan 2024€32.5b€7.3b€507.1m35.5x64.2x4.5x
Thu, 30 Nov 2023€28.6b€7.3b€507.1m30x56.4x3.9x
Sat, 28 Oct 2023€24.4b€6.4b€356.1m36.6x68.6x3.8x
Mon, 25 Sep 2023€26.8b€6.6b€498.1m38.7x53.7x4x
Wed, 23 Aug 2023€29.2b€6.6b€425.8m42.8x68.6x4.5x
Price to Earnings Ratio

68.6x


Total Market Cap: €29.2bTotal Earnings: €425.8mTotal Revenue: €6.6bTotal Market Cap vs Earnings and Revenue0%0%0%
German Life Sciences Industry Price to Earnings3Y Average 105.8x202420252026
Current Industry PE
  • Investors are pessimistic on the German Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 3.2x is higher than the industry's current PS ratio of 2.6x.
Past Earnings Growth
  • Total earnings for the Life Sciences industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 5.2% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the German Healthcare industry?

DE Market0.22%
Healthcare-2.27%
Life Sciences1.36%
Clinical Research and Equipment1.36%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GXI Gerresheimer€27.163.3%
+€29.7m
-39.7%PS0.4x

Latest News